Inflammation

Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects
Margrethe Flesvig Holt, Bjørn E Seim, Jonas Øgaard, Maria B Olsen, Per R Woldbæk, John-Peder Escobar Kvitting, Pål Aukrust, Arne Yndestad, Tom Eirik Mollnes, Per H Nilsson, Mieke C Louwe, Trine Ranheim

Open Heart Nov 2019, 6 (2) e001098; DOI: 10.1136/openhrt-2019-001098
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
Anne Kristine Anstensrud, Sindre Woxholt, Kapil Sharma, Kaspar Broch, Bjørn Bendz, Svend Aakhus, Thor Ueland, Brage H Amundsen, Jan Kristian Damås, Einar Hopp, Ola Kleveland, Knut Haakon Stensæth, Anders Opdahl, Nils-Einar Kløw, Ingebjørg Seljeflot, Geir Øystein Andersen, Rune Wiseth, Pål Aukrust, Lars Gullestad

Open Heart Oct 2019, 6 (2) e001108; DOI: 10.1136/openhrt-2019-001108
Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
Colin G Stirrat, Shirjel Alam, Thomas J MacGillivray, Calum Gray, Marc Richard Dweck, Victor Jones, William Wallace, John R Payne, Sanjay K Prasad, Roy S Gardner, Mark C Petrie, Saeed Mirsadraee, Peter Henriksen, David E Newby, Scott Semple

Open Heart Oct 2019, 6 (2) e001115; DOI: 10.1136/openhrt-2019-001115
Coronary artery calcium, HIV and inflammation in Uganda compared with the USA
Ben Alencherry, Geoffrey Erem, Grace Mirembe, Isaac Ssinabulya, Chun-Ho Yun, Chung-Lieh Hung, Mark J Siedner, Marcio Bittencourt, Cissy Kityo, Grace A McComsey, Chris T Longenecker

Open Heart May 2019, 6 (1) e001046; DOI: 10.1136/openhrt-2019-001046
Importance of maintaining a low omega–6/omega–3 ratio for reducing inflammation
James J DiNicolantonio, James H O’Keefe

Open Heart Nov 2018, 5 (2) e000946; DOI: 10.1136/openhrt-2018-000946
Risk classification in primary prevention of CVD according to QRISK2 and JBS3 ‘heart age’, and prevalence of elevated high-sensitivity C reactive protein in the UK cohort of the EURIKA study
Ieuan Johns, Konstantinos E Moschonas, Jesús Medina, Nicholas Ossei-Gerning, George Kassianos, Julian P Halcox

Open Heart Nov 2018, 5 (2) e000849; DOI: 10.1136/openhrt-2018-000849
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
Thor Ueland, Ola Kleveland, Annika E Michelsen, Rune Wiseth, Jan Kristian Damås, Pål Aukrust, Lars Gullestad, Bente Halvorsen, Arne Yndestad

Open Heart Sep 2018, 5 (2) e000765; DOI: 10.1136/openhrt-2017-000765
Impact of periodontitis as representative of chronic inflammation on long-term clinical outcomes in patients with atrial fibrillation
Sung Il Im, Jinho Heo, Bong Joon Kim, Kyoung-Im Cho, Hyun Su Kim, Jung Ho Heo, Jin Yong Hwang

Open Heart Apr 2018, 5 (1) e000708; DOI: 10.1136/openhrt-2017-000708
SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis
Gethin W Hodges, Casper N Bang, Jesper Eugen-Olsen, Michael H Olsen, Kurt Boman, Simon Ray, Antero Y Kesäniemi, Jørgen L Jeppesen, Kristian Wachtell

Open Heart Jan 2018, 5 (1) e000743; DOI: 10.1136/openhrt-2017-000743
Cardioprotection by an anti-MASP-2 antibody in a murine model of myocardial infarction
James, E Clark, Thomas Dudler, Michael, S Marber, Wilhelm Schwaeble

Open Heart Jan 2018, 5 (1) e000652; DOI: 10.1136/openhrt-2017-000652

Main menu

Inflammation

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Inflammation

Pages